TherapeuticsMD Inc. (TXMD)
1.00
-0.04 (-3.85%)
At close: Jan 14, 2025, 3:59 PM
1.04
4.30%
Pre-market Jan 15, 2025, 04:05 AM EST
undefined% (undefined)
| Bid | 0.98 |
| Market Cap | 11.50M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.35 |
| PE Ratio (ttm) | -2.85 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 1.18 |
| Volume | 107,112 |
| Avg. Volume (20D) | 293,226 |
| Open | 1.00 |
| Previous Close | 1.04 |
| Day's Range | 0.99 - 1.07 |
| 52-Week Range | 0.70 - 2.75 |
| Beta | undefined |
About TXMD
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone...
Sector Healthcare
IPO Date May 9, 2007
Employees 1
Stock Exchange NASDAQ
Ticker Symbol TXMD
Website https://www.therapeuticsmd.com
Analyst Forecast
According to 1 analyst ratings, the average rating for TXMD stock is "Hold." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 0.00%
Hold 100.00%
Sell 0.00%
